newsfilter
← Latest News
PR Newswire·

Poseida Therapeutics to Join Russell 3000® and Russell 2000® Indexes

SAN DIEGO, June 26, 2023 /PRNewswire/ -- Poseida Therapeutics, Inc. (NASDAQ:PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today